Background: The aim of this study was to analyze the U-wave morphology and its relation to the T-wave in one group of healthy subjects and in two groups of myocardial infarction (MI) patients-with and without ventricular tachycardia (VT) episodes. The context of the U-wave origin was also discussed and the U-wave as a potential marker of VT was investigated.
Methods: The study was carried out on three groups of subjects: 20 healthy subjects, 14 MI patients not at risk of VT, and 22 MI patients at risk of VT. The morphology of the repolarization phase was examined in the high-resolution body surface potential maps recorded from 64 surface ECG leads. The temporal and spatial distributions of several ECG parameters were studied.
Results: The U-wave was present in almost all the studied subjects. The spatial heterogeneity and smooth change in both the T- and U-wave shapes on the entire torso were observed in all the studied groups. The statistical significance of discrimination between the MI patients without VT and MI patients with VT was observed for QRS interval, QT interval, U-wave integral, and normalized U-wave integral.
Conclusions: High-resolution measurement of body surface potentials and an advanced data analysis allow for a detailed description of U-wave morphology and its relation to the T-wave. This might be of value in discriminating intracardiac repolarization effects, mechano-electrical feedback, and arrhythmia risk stratification.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6932608 | PMC |
| http://dx.doi.org/10.1111/anec.12110 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
A comparative cohort study of post-COVID-19 conditions based on physical examination records in China.
EBioMedicine
January 2025
Biomedical Big Data Center, The First Affiliated Hospital of Zhejiang University School of Medicine, Zhejiang, China. Electronic address:
Background: Coronavirus disease-2019 (COVID-19), caused by SARS-CoV-2 virus infection, is characterized as a multisystem disease, potentially yielding multifaceted consequences on various organs at multiple levels. At the end of 2022, over 90% of the Chinese population was infected by SARS-CoV-2 within 35 days because of adjustments to epidemic prevention and control policies. This short-term change provides an unprecedented opportunity for comparative studies on COVID-19 infection among large populations.
View Article and Find Full Text PDFA Phase 1 Study of FHD-609, a Heterobifunctional Degrader of Bromodomain-Containing Protein 9, in Patients With Advanced Synovial Sarcoma or SMARCB1-Deficient Tumors.
Clin Cancer Res
December 2024
Dana-Farber Cancer Institute, Boston, United States.
Purpose: FHD-609, a potent, selective, heterobifunctional degrader of bromodomain-containing protein 9 (BRD9), was evaluated for treatment of patients with advanced synovial sarcoma (SS) or SMARCB1-deficient tumors.
Patients And Methods: In this multinational, open-label, phase 1 study (NCT04965753), patients received FHD609 intravenously at escalating doses either twice weekly (BIW) (5 to 80 mg; n=40) or once weekly (QW) (40 to 120 mg; n=15).
Results: Fifty-five patients received FHD-609 for a median of 43 days.
Digital Electrocardiographic Complex for Risk Stratification of Paroxysmal Atrial Fibrillation.
Sovrem Tekhnologii Med
December 2024
MD, PhD, Leading Researcher, Laboratory of Medical Information Technologies; Republican Scientific and Practical Centre "Cardiology", Ministry of Health of the Republic of Belarus, 110 R. Luxembourg St., Minsk, 220036, Belarus.
Unlabelled: was to develop and clinically test a hardware and software system capable of identifying the predictors of the hidden forms of atrial fibrillation (AF) using 12-lead ECG data in sinus rhythm.
Materials And Methods: There was developed the hardware and software system "Intecard 8.1" to assess a set of markers for atrial electrical instability by 3-5-minute ECG recordings in sinus rhythm.
Acquired Type 1 Brugada Syndrome Induced by Chronic High-Dose Kratom Use.
Cureus
October 2024
Department of Emergency Medicine, Memorial Healthcare System, Hollywood, USA.
Article Synopsis
- Kratom, a natural substance used for chronic pain and opioid withdrawal, has been linked to serious heart conditions, particularly Brugada syndrome.
- A 36-year-old male with a history of substance abuse and underlying health conditions experienced chest pain, lightheadedness, and palpitations after using high doses of kratom for three years.
- His case revealed a type 1 Brugada pattern on an EKG, leading to the diagnosis of Brugada syndrome as a result of chronic kratom use, emphasizing the need for medical professionals to be aware of the potential severe cardiac risks associated with kratom.
Electrocardiographic Strain and Relationship with Left Ventricular Remodelling and Clinical Outcomes in Patients with Aortic Stenosis Undergoing Transcatheter Aortic Valve Implantation.
Cardiology
November 2024
Department of Heart Disease, Haukeland University Hospital, Bergen, Norway.
Introduction: Left ventricular (LV) remodelling and fibrosis are known to occur in patients with aortic stenosis (AS) and are linked to post-intervention outcomes. These myocardial changes may be detected upon the routine 12-lead electrocardiogram (ECG) by the presence of a LV strain pattern (LVS-ECG). Although LVS-ECG has been related to excessive cardiovascular morbidity and mortality in multiple patient populations, there is currently a dearth of data upon its impact in patients undergoing transcatheter aortic valve implantation (TAVI).
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!